CH BIOTECH SER: (1) PROPOSED GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED ELECTION OF NEW DIRECTOR; (3) PROPOSED ADOPTION OF THE 2024 SHARE OPTION SCHEME; AND (4) NOTICE OF ANNUAL GENER

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

中國生物科技服務：(1)建議授予購回股份及發行新股份之一般授權；(2)建議重選退任董事及建議選舉新董事；(3)建議採納二零二四年購股權計劃；及(4)股東週年大會通告

CH BIOTECH SER: (1) PROPOSED GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED ELECTION OF NEW DIRECTOR; (3) PROPOSED ADOPTION OF THE 2024 SHARE OPTION SCHEME; AND (4) NOTICE OF ANNUAL GENER

Risk Disclaimer

Statement